menu search

CELU / Celularity, Inc. (CELU) Q3 Earnings Beat Estimates

Celularity, Inc. (CELU) Q3 Earnings Beat Estimates
Celularity, Inc. (CELU) delivered earnings and revenue surprises of 111.54% and 21.83%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? Read More
Posted: Nov 10 2022, 21:49
Author Name: Zacks Investment Research
Views: 103018

CELU News  

Celularity, Inc. (CELU) Is a Trending Stock: Facts to Know Before Betting on It

By Zacks Investment Research
March 17, 2023

Celularity, Inc. (CELU) Is a Trending Stock: Facts to Know Before Betting on It

Celularity, Inc. (CELU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can imp more_horizontal

Here is What to Know Beyond Why Celularity, Inc. (CELU) is a Trending Stock

By Zacks Investment Research
February 20, 2023

Here is What to Know Beyond Why Celularity, Inc. (CELU) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Celularity, Inc. (CELU). This makes it worthwhile to examine what the stock has in store more_horizontal

Celularity, Inc. (CELU) is Attracting Investor Attention: Here is What You Should Know

By Zacks Investment Research
February 8, 2023

Celularity, Inc. (CELU) is Attracting Investor Attention: Here is What You Should Know

Celularity, Inc. (CELU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can imp more_horizontal

Celularity, Inc. (CELU) Is a Trending Stock: Facts to Know Before Betting on It

By Zacks Investment Research
January 24, 2023

Celularity, Inc. (CELU) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Celularity, Inc. (CELU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's more_horizontal

Investors Heavily Search Celularity, Inc. (CELU): Here is What You Need to Know

By Zacks Investment Research
January 11, 2023

Investors Heavily Search Celularity, Inc. (CELU): Here is What You Need to Know

Zacks.com users have recently been watching Celularity, Inc. (CELU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's more_horizontal

After Plunging -38.63% in 4 Weeks, Here's Why the Trend Might Reverse for Celularity, Inc. (CELU)

By Zacks Investment Research
January 9, 2023

After Plunging -38.63% in 4 Weeks, Here's Why the Trend Might Reverse for Celularity, Inc. (CELU)

Celularity, Inc. (CELU) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined wit more_horizontal

Down 29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Celularity, Inc. (CELU)

By Zacks Investment Research
December 23, 2022

Down 29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Celularity, Inc. (CELU)

Celularity, Inc. (CELU) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement more_horizontal

All You Need to Know About Celularity, Inc. (CELU) Rating Upgrade to Strong Buy

By Zacks Investment Research
December 20, 2022

All You Need to Know About Celularity, Inc. (CELU) Rating Upgrade to Strong Buy

Celularity, Inc. (CELU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Stro more_horizontal


Search within

Pages Search Results: